Blood Review Series: Strategies to Improve Graft-Versus-Leukemia Effects
2,559 views · Published 8 March 2018 · 6:48 · Indexed 28 October 2026
Channel: American Society of Hematology · 2018 · Nonprofits & Activism
Robert Zeiser, MD & Michel Sadelain, MD, PhD discuss highlights of this review series, which explores exciting new developments in treatments to enhance graft-versus-leukemia (GVL) effects in hematopoietic cell transplantation, including cellular therapies, antibody-based treatments, and drug-based approaches using tyrosine kinase inhibitors and checkpoint blockade. Members of The American Society of Hematology (ASH) can read articles from this review series at: http://www.bloodjournal.org/page/review-series/gvl
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding